Trial site
The Second Affiliated Hospital of Zhengzhou University
- 23running trials
- 18closed trials
The trials here
What the 41 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes14 trials
- Obesity9 trials
- Ulcerative colitis7 trials
- Crohn's disease4 trials
- Liver and biliary tract cancer2 trials
- Ovarian cancer2 trials
- Atrial fibrillation1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Hepatitis B1 trial
- Insomnia1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 329 trials
- Phase 25 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 41 trial
- Status
- Completed18 trials
- Recruiting9 trials
- Not yet recruiting8 trials
- Active, not recruiting6 trials
- Lead sponsor
- Eli Lilly and Company12 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.3 trials
- Hoffmann-La Roche3 trials
- Boehringer Ingelheim2 trials
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- and 16 more
Running trials
Recruiting
Recruiting
Recruiting
Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®
Recruiting
Recruiting
Not yet recruiting
A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Recruiting
Recruiting
Recruiting
Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease4 recruiting
- Obesity3 recruiting
- Ulcerative colitis3 recruiting
- Liver and biliary tract cancer2 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Hepatitis B1 recruiting
- Pancreatic cancer1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder
Completed
To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Completed
A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Completed
Completed
Completed
Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026